These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8824721)

  • 1. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas.
    Carbonara C; Longa L; Grosso E; Mazzucco G; Borrone C; Garrè ML; Brisigotti M; Filippi G; Scabar A; Giannotti A; Falzoni P; Monga G; Garini G; Gabrielli M; Riegler P; Danesino C; Ruggieri M; Magro G; Migone N
    Genes Chromosomes Cancer; 1996 Jan; 15(1):18-25. PubMed ID: 8824721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
    Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
    Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
    Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor.
    Green AJ; Johnson PH; Yates JR
    Hum Mol Genet; 1994 Oct; 3(10):1833-4. PubMed ID: 7849709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene.
    Carbonara C; Longa L; Grosso E; Borrone C; Garrè MG; Brisigotti M; Migone N
    Hum Mol Genet; 1994 Oct; 3(10):1829-32. PubMed ID: 7849708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.
    Green AJ; Smith M; Yates JR
    Nat Genet; 1994 Feb; 6(2):193-6. PubMed ID: 8162074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity in tuberous sclerosis hamartomas.
    Sepp T; Yates JR; Green AJ
    J Med Genet; 1996 Nov; 33(11):962-4. PubMed ID: 8950679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
    Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ
    Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.
    Henske EP; Scheithauer BW; Short MP; Wollmann R; Nahmias J; Hornigold N; van Slegtenhorst M; Welsh CT; Kwiatkowski DJ
    Am J Hum Genet; 1996 Aug; 59(2):400-6. PubMed ID: 8755927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
    Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
    Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biallelic TSC gene inactivation in tuberous sclerosis complex.
    Crino PB; Aronica E; Baltuch G; Nathanson KL
    Neurology; 2010 May; 74(21):1716-23. PubMed ID: 20498439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tests for loss of heterozygosity in tuberous sclerosis].
    Jóźwiak S; Dabora S; Kasprzyk-Obara J; Domańska-Pakieła D; Grajkowska W
    Przegl Lek; 2001; 58 Suppl 1():12-5. PubMed ID: 11355103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.
    Jones AC; Shyamsundar MM; Thomas MW; Maynard J; Idziaszczyk S; Tomkins S; Sampson JR; Cheadle JP
    Am J Hum Genet; 1999 May; 64(5):1305-15. PubMed ID: 10205261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.